Clinical Trial Update: Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nitroglycerin plus intracranial radiotherapy versus radiotherapy alone in NSCLC patients with brain metastases; trial complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Phase II Clinical Trial, Ninety-six Histologically Confirmed NSCLC Patients With BM | Phase 2 | Status: COMPLETED